We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.34B
AUM Growth
-$237M
Cap. Flow
-$130M
Cap. Flow %
-2.43%
Top 10 Hldgs %
17.36%
Holding
1,615
New
114
Increased
629
Reduced
604
Closed
130

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.6M
2
AAPL icon
Apple
AAPL
+$16.6M
3
NVDA icon
NVIDIA
NVDA
+$14.2M
4
IDXX icon
Idexx Laboratories
IDXX
+$13.7M
5
XPO icon
XPO
XPO
+$13.2M

Sector Composition

Rank Sector Weight
1 Technology 18.05%
2 Financials 11.09%
3 Healthcare 10.47%
4 Consumer Discretionary 9.45%
5 Industrials 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
26
Bank of America
BAC
$433B
$27.4M 0.51%
645,675
-32,040
-5% -$1.29M
DIS icon
27
Walt Disney
DIS
$167B
$27M 0.51%
159,681
+6,865
+4% +$1.22M
MRNA icon
28
Moderna
MRNA
$23B
$26.5M 0.5%
68,766
-21,558
-24% -$7.95M
SPY icon
29
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$24.6M 0.46%
57,400
+3,027
+6% +$1.34M
CSCO icon
30
Cisco
CSCO
$448B
$24.4M 0.46%
448,747
-7,852
-2% -$441K
WMT icon
31
Walmart Inc
WMT
$884B
$24.2M 0.45%
521,337
+10,671
+2% +$514K
PG icon
32
Procter & Gamble
PG
$335B
$23.9M 0.45%
171,006
-1,804
-1% -$256K
MTUM icon
33
iShares MSCI USA Momentum Factor ETF
MTUM
$24.9B
$23.6M 0.44%
134,657
+3,235
+2% +$575K
PEP icon
34
PepsiCo
PEP
$191B
$23.2M 0.43%
154,085
-1,826
-1% -$283K
BABA icon
35
Alibaba
BABA
$279B
$23.2M 0.43%
156,496
-10,840
-6% -$1.97M
NEE icon
36
NextEra Energy
NEE
$183B
$22.9M 0.43%
291,521
+1,860
+0.6% +$150K
VCSH icon
37
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.8B
$22.6M 0.42%
274,053
+46,672
+21% +$3.86M
TMO icon
38
Thermo Fisher Scientific
TMO
$214B
$22.6M 0.42%
39,526
-4,663
-11% -$2.56M
MDT icon
39
Medtronic
MDT
$110B
$22.6M 0.42%
180,018
+4,959
+3% +$642K
IJR icon
40
iShares Core S&P Small-Cap ETF
IJR
$110B
$21.8M 0.41%
199,764
+11,409
+6% +$1.26M
SHY icon
41
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$21.6M 0.4%
250,820
+72,941
+41% +$6.29M
HON icon
42
Honeywell
HON
$76.7B
$21.2M 0.4%
106,013
-3,715
-3% -$792K
LOW icon
43
Lowe's Companies
LOW
$118B
$21.2M 0.4%
104,314
+866
+0.8% +$173K
MRK icon
44
Merck
MRK
$321B
$20.9M 0.39%
278,256
-5,916
-2% -$450K
ABBV icon
45
AbbVie
ABBV
$455B
$20.5M 0.38%
190,196
+6,956
+4% +$795K
PWR icon
46
Quanta Services
PWR
$98.7B
$20.2M 0.38%
177,191
-150
-0.1% -$15K
ACN icon
47
Accenture
ACN
$99.9B
$19.9M 0.37%
62,233
+1,806
+3% +$587K
IJH icon
48
iShares Core S&P Mid-Cap ETF
IJH
$122B
$19.9M 0.37%
378,320
-9,515
-2% -$512K
MA icon
49
Mastercard
MA
$510B
$19.7M 0.37%
56,757
+122
+0.2% +$44.4K
AMGN icon
50
Amgen
AMGN
$209B
$19.7M 0.37%
92,678
-1,301
-1% -$299K

Similar funds

Oppenheimer & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Oppenheimer & Co held 1,615 positions worth $5.34B, down 4.2% from $5.58B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q3 2021 filing shows 114 new, 629 increased, 604 reduced and 130 closed positions. Its largest new stake was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K. The largest sale was Microsoft, an estimated $17.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q3 2021 buy was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K.
  • Oppenheimer & Co added most to Invesco Ultra Short Duration ETF in Q3 2021, an estimated $9.29M increase.
  • Oppenheimer & Co's biggest Q3 2021 reduction was Microsoft, cutting an estimated $17.6M.
  • Oppenheimer & Co fully exited Pricesmart in Q3 2021, selling an estimated $6.18M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $5.34B portfolio in Q3 2021.
  • Oppenheimer & Co opened 114 new positions and closed 130 in Q3 2021.
  • Oppenheimer & Co's portfolio value fell 4.2% quarter-over-quarter to $5.34B.

Based on Oppenheimer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.